Pulmonary embolism: from diagnosis to prognosis and treatment

Poster Discussion
Chairs: S. Ramjug (Altrincham, United Kingdom), D. Jiménez Castro (Madrid, Spain)

Late Breaking Abstract - Frequency Pulmonary embolism (PE) in patients with an acute Exacerbation of chronic obstructive Pulmonary disease (COPD). PEP prospective trial. F. Couturaud (Brest, France), L. Bertoletti (St Etienne, France), O. Sanchez (Paris, France), R. Le Mao (Brest, France), P. Roy (Angers, France), F. Gagnadoux (Angers, France), N. Paleiron (Toulon, France), J. Schmidt (Clermont-Ferrand, France), J. Pastre (Paris, France), E. De Magalhaes (St Etienne, France), Y. Auffret (Quimper, France), C. Hoffmann (Brest, France), L. Bressollette (Brest, France), M. Nonent (Brest, France), P. Salaun (Brest, France), P. Mismetti (St Etienne, France), P. Girard (Paris, France), K. Lacut (Brest, France), C. Lemarié (Brest, France), C. Tromeur (Brest, France), G. Meyer (Paris, France), C. Leroyer (Brest, France)
The impact of implementing a modified YEARS algorithm on the diagnosis of pulmonary embolism T. Lim (Singapore, Singapore), J. Zhang (Singapore, Singapore), Y. Goh (Singapore, Singapore)
Incorporating age adjusted d-dimer limit in place of differential cut-off in YEARS algorithm. Does it help to reduce CTPA burden? A. Zahid (Stoke-on-Trent, United Kingdom), A. Azam (Stoke-on-Trent, United Kingdom), Q. Abdullah (Stoke-on-Trent, United Kingdom), I. Hamigi (Stoke-on-Trent, United Kingdom), A. Kodamanchile (Stoke-on-Trent, United Kingdom), S. Ekhelikar (Stoke-on-Trent, United Kingdom), M. Ganaie (Stoke-on-Trent, United Kingdom)
Streamlining diagnostic work-up of pulmonary embolism: Comparing YEARS algorithm with original and simplified Well’s scores A. Zahid (Stoke-on-Trent, United Kingdom), A. Azam (Stoke-on-Trent, United Kingdom), Q. Abdullah (Stoke-on-Trent, United Kingdom), I. Hamigi (Stoke-on-Trent, United Kingdom), A. Kodamanchile (Stoke-on-Trent, United Kingdom), S. Ekhelikar (Stoke-on-Trent, United Kingdom), M. Ganaie (Stoke-on-Trent, United Kingdom)
Can implementation of the pulmonary embolism rule-out criteria (PERC) safely reduce D-dimer and CTPA requests in a two-tier Wells model? H. Ang (Newport, United Kingdom), H. Tan (Newport, United Kingdom), A. Ionescu (Newport, United Kingdom)
Assessment of myocardial injury in low-risk acute pulmonary embolism D. Jiménez Castro (Madrid, Spain), A. Quezada (Madrid, Spain), J. Lobo (Vitoria, Spain), R. Morillo (Madrid, Spain), E. Barbero (Madrid, Spain), D. Chiluiza (Madrid, Spain), E. Mercedes (Madrid, Spain), F. León (Madrid, Spain), D. Barrios (Madrid, Spain), R. Yusen (St. Louis, United States of America)
Modification of the simplified PESI score to identify low risk patients with acute symptomatic pulmonary embolism D. Chiluiza Reyes (Madrid, Spain), E. Barbero (Madrid, Spain), A. Quezada (Madrid, Spain), E. Mercedes (Madrid, Spain), F. León (Madrid, Spain), D. Jiménez (Madrid, Spain)
Sincope is a risk marker in Pulmonary Embolism (PE) with a low risk clinical profile (sPESI:0) K. Fernandez De Roitegui Perez (Vitoria Gasteiz, Spain), J. Lobo Beristain (Vitoria Gasteiz, Spain), I. Murga Arizabaleta (Vitoria Gasteiz, Spain), C. Bermudez Ampudia (Vitoria Gasteiz, Spain), A. Maestre (Alicante, Spain), F. Garcia Bragado (Gerona, Spain), R. Otero (Sevilla, Spain), M. Peris (Castellón, Spain), J. Lopez Núlez (Badalona, Spain), P. Verhamme (Leuven, Belgium), M. Monreal (Barcelona, Spain), Riete (Spain, Spain)
Prevalence of pulmonary embolism in patients with isolated syncope in the emergency department: the PEEPS multicenter prospective cohort study. Y. Freund (Paris, France), A. Philippon (Paris, France), A. Feral-Pierssens (Paris, France), C. Damas Perrichet (Paris, France), S. Boussouar (Paris, France), V. Donciu (Paris, France), M. Cachanado (Paris, France), P. Raynal (Paris, France)
Refining risk in normotensive acute pulmonary embolism K. Solverson (Calgary, Canada), C. Humphreys (Calgary, Canada), Z. Liang (Calgary, Canada), P. Boiteau (Calgary, Canada), A. Freland (Calgary, Canada), E. Herget (Calgary, Canada), J. Andruwchow (Calgary, Canada), N. Fine (Calgary, Canada), D. Helmersen (Calgary, Canada), J. Weatherald (Calgary, Canada)
Association between risk stratification for pulmonary embolism and deep vein thrombosis of lower extremities X. Wang (ChongqingChongqing, China), H. Chen (ChongqingChongqing, China), L. Yang (ChongqingChongqing, China)
Presentation and clinical evolution of Pulmonary Embolism in patients with Mental Disorders C. Martin Ontiyuelo (Barcelona, Spain), O. Caguana Vélez (Barcelona, Spain), A. Herranz Blasco (Barcelona, Spain), A. Sancho Muñoz (Barcelona, Spain), L. Molina Ferragut (Barcelona, Spain), R. Millán Segovia (Barcelona, Spain), A. Vazquez Sanchez (Barcelona, Spain), O. Pallas Villaronga (Barcelona, Spain), M. Mellado Joan (Barcelona, Spain), F. Fernández Alarza (Barcelona, Spain), C. Jiménez Martínez (Barcelona, Spain), J. Masclans Enviz (Barcelona, Spain), C. Estirado Vera (Barcelona, Spain), D. Rodriguez Chiaradía (Barcelona, Spain)
COPD is an indipendent risk factor for in-situ pulmonary artery thrombosis P. Intiglietta (bari, Italy), M. Peragine (Acquaviva delle Fonti, Italy), P. Buonamico (bari, Italy), G. Castellana (Cassano delle Murge, Italy), O. Resta (bari, Italy)
Factors related to hospital stay of patients with pulmonary thromboembolism J. Hernandez Borge (Badajoz, Spain), L. Sierra Murillo (Badajoz, Spain), K. El Boutaibi Faiz (Badajoz, Spain), P. Cordero Montero (Badajoz, Spain), A. Castañar Jover (Badajoz, Spain), M. Gomez Vizcaino (Badajoz, Spain), A. Sanz Cabrera (Badajoz, Spain), F. Marquez Perez (Badajoz, Spain)
Effectiveness of the tromboembolic venous disease treatments estimated through clinical trials vs. observational studies E. Barbero Herranz (Madrid, Spain), C. Coscia (Madrid, Spain), A. Jaureguizar (Madrid, Spain), C. Quezada (Madrid, Spain), A. Muriel (Madrid, Spain), M. Monreal (Barcelona, Spain), T. Villén (Madrid, Spain), D. Chiluiza (Madrid, Spain), J. Yusen (Missouri y Cajal Hospital, United States of America), D. Jiménez (Madrid, Spain)
Half-dose thrombolysis for intermediate-high risk pulmonary embolism: Case series from a London hospital R. Gupta (London, United Kingdom), K. Philip (London, United Kingdom), T. Harris (London, United Kingdom)
Should thrombolysis and sildenafil be given in the acute management of patients with large pulmonary embolism? An assessment of the short and long-term outcomes. N. Hill (London, United Kingdom), N. Bascon (London, United Kingdom), N. Barnes (London, United Kingdom), B. Madden (London, United Kingdom)
Rivaroxaban versus standard anticoagulation for the treatment of pulmonary embolism: a real-life study C. Vigneron (Paris, France), A. Vivot (Paris, France), M. Jamme (Poissy, France), A. Gibelin (Paris, France), G. Briend (Paris, France), J. Pastré (Paris, France), B. Planquette (Paris, France), G. Meyer (Paris, France), O. Sanchez (Paris, France)